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Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging disease that was first reported
in China in 2011. It is caused by SFTS virus (SFTSV) which is a member of the Phlebovirus genus in the Bunyaviridae
family. SFTSV has been classified as a BSL3 pathogen. There is a need to develop safe and affordable serodiagnostic
methods for proper clinical management of infected patients.
Methods: The full length nucleocapsid (N) gene of SFTSV Yamaguchi strain was amplified by RT-PCR and cloned to
an expression vector pQE30. The recombinant (r) SFTSV-N protein was expressed by using Escherichia coli (E. coli)
expression system and purified under native conditions. rSFTSV-N protein based indirect IgG and IgM enzyme
linked immunosorbent assay (ELISA) systems were established to detect specific human IgG and IgM antibodies,
respectively. One hundred fifteen serum samples from clinically suspected-SFTS patients were used to evaluate the
newly established systems and the results were compared with the total antibody detecting sandwich ELISA system.
Results: The native form of recombinant (r) SFTSV-N protein was expressed and purified. Application of the rSFTSV-N
protein based indirect IgG ELISA to the 115 serum samples showed results that perfectly matched those of the total
antibody sandwich ELISA with a sensitivity and specificity of 100 %. The rSFTSV-N protein based indirect IgM ELISA
missed 8 positive samples that were detected by the total antibody sandwich ELISA. The sensitivity and specificity of
rSFTSV-N-IgM capture ELISA were 90.59 and 100 %, respectively.
Conclusions: The rSFTSV-N protein is highly immunoreactive and a good target for use as an assay antigen in
laboratory diagnosis. Its preparation is simpler in comparison with that used for the total antibody sandwich
system. Our rSFTSV-N protein-based IgG and IgM ELISA systems have the advantage of distinguishing two types
of antibodies and require small volume of serum sample only. They are safe to use for diagnosis of SFTS virus
infection and especially fit in large-scale epidemiological investigations.
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Background
Severe fever with thrombocytopenia syndrome virus
(SFTSV), also named as fever, thrombocytopenia and
leukopenia syndrome virus (FTLSV) or Huaiyangshan
virus, is an emergent virus that was first reported in
2011 [1–3]. The sources of serum samples where the virus
was identified were from patients infected in 2009 and
2010 in China. Severe fever with thrombocytopenia syn-
drome (SFTS), the disease caused by the virus has a major
clinical presentations that include fever, thrombocytopenia,
leukocytopenia, gastrointestinal symptoms, neurological
symptoms, bleeding tendency, as well as less specific clin-
ical manifestations [1, 2]. This disease has a case-fatality
rate ranging from 2.5 to 30 % in different areas of en-
demicity [4]. Human-to-human transmission of SFTSV
was reported to occur through close contact with the
blood and/or body secretions of infected patients [5–9].
After the first identification of SFTS, SFTS cases have
been reported in 13 provinces of China [10]. Recently,
the existence of this disease has also been confirmed in
Japan and South Korea [11–15]. In Japan, the case-fatality
rate of 55 % (6/11) was apparently higher than that in
China, where an average of 12 % of cases was fatal [13].
Data on the high fatality rate due to SFTSV indicate that
SFTSV is a threat to human health. Another tick-borne
phlebovirus, the Heartland virus, which was detected in
Missouri, is phylogenetically associated with SFTSV. It
causes severe febrile illness with thrombocytopenia,
leukopenia in the total blood cell count, and elevated
levels of liver enzymes [16].
For the diagnosis of SFTS, laboratory confirmation is
essential because the clinical manifestations of SFTS are
non-specific. Virus isolation from the blood of viremic
patients is the direct evidence of SFTSV infection, how-
ever, it is time-consuming and needs high security bio-
containment facility [1, 2]. Detection of SFTSV genome
could be achieved by different nucleic acid detection
techniques such as reverse transcription-PCR (RT-PCR)
[1, 2], real-time RT-PCR [14, 17], reverse transcription-
loop-mediated isothermal amplification assay (RT-LAMP)
[18–20], reverse transcription-cross-priming amplification
coupled (RT-CPA) with vertical flow (VF) visualization
[21]. Although these techniques have high sensitivity and
specificity in early diagnosis, the duration of viraemia in
SFTSV infection is very short, generally 1–6 days after the
disease onset [22]. Hence, the nucleic acid detecting tech-
niques are applicable only during the acute phase of the
disease which is within 1 week after its onset. The final
confirmation of infection in many cases may rely on the
detection of the specific antibodies to SFTSV.
SFTSV is a member of the Phlebovirus genus in the
Bunyaviridae family. Like other bunyaviruses, the L seg-
ment encodes the RNA-dependent RNA polymerase; the
M segment has an open reading frame (ORF) coding for
a GnGc precursor in the order Gn-Gc; whereas the S
segment uses ambisense coding to express two proteins:
one is a nucleocapsid (N) protein encoded by the 5′ half
of viral complementary sense S RNA, and the other is a
nonstructural (NS) protein encoded by viral sense S
RNA [1, 2, 23]. Nucleocapsid (N) protein is one of the
most immunodominant viral proteins among members
of the Bunyaviridae family. Recombinant N protein of
Rift Valley Fever (RVF) virus, another member of the
Phlebovirus genus, was reported to be used in a detec-
tion system for the laboratory diagnosis of RFV infection
in humans and animals [24–26]. In SFTSV, Jiao et al.
developed a recombinant N protein based sandwich en-
zyme linked immunosorbent assay (ELISA) for detecting
the total antibodies against this virus in humans and ani-
mals [27]. In our present report, recombinant SFTSV-N
(rSFTSV-N) protein was expressed by using Escherichia coli
(E. coli) expression system and then purified. rSFTSV-N
protein based IgG ELISA and IgM ELISA systems were
established. Serum samples from clinically-suspected SFTS
patients were used to evaluate the newly established
systems and results were compared with those obtained
by using the total antibody detecting sandwich ELISA
system.
Results
Expression and purification of rSFTSV-N protein
The SFTSV nucleocapsid gene encoding amino acid resi-
dues 1–246 of the full length nucleocapsid protein was
successfully amplified by RT-PCR and cloned into an
expression vector in frame and downstream of the six-
histidine tag (Fig. 1a). The sequence and reading frame
of the N gene were confirmed by DNA sequencing of
the recombinant plasmid. The recombinant protein was
successfully expressed in E. coli. Most of the expressed
protein was soluble (Fig.1b lane 2). The rSFTSV-N pro-
tein was purified from the supernatant under native
conditions. Analysis of purified recombinant protein by
SDS-PAGE and Coomassie blue staining revealed a
single protein band of 26kD as predicted by the amino
acid sequence of the nucleocapsid protein (Fig. 1b lane
4). The identity of the rSFTSV-N protein was further con-
firmed by Western blot assay with mouse monoclonal
antibody against histidine and the use of SFTS patient
serum sample (Fig. 2).
Determination of serum dilutions for indirect IgG and IgM
To determine the appropriate dilutions of serum sam-
ples for the indirect IgG and IgM ELISAs using the
rSFTSV-N protein mentioned above, samples from
healthy volunteers and SFTS confirmed patients were di-
luted two-fold from 1:100 up to 1:1000. After the appli-
cation of IgG ELISA to 94 serum samples from healthy
volunteers, 9 gave an optical density (OD) value of 0.5 at
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1:400 and lower dilutions of the samples. At higher dilu-
tions, 1:800 and 1:1000, the OD values of all the samples
were between 0.1-0.2. The OD values of two serum sam-
ples for SFTS-confirmed patients did not change much;
the value was 3.0 at 1:100 dilution and was reduced only
to 2.4 at 1:1000 dilution. Based on these results, the dilu-
tion of serum samples for IgG ELISA was set at 1:1000
for convenience.
In IgM ELISA, 12 of the healthy volunteer samples
gave an OD value of 0.5 in 1:100 and 1:200 dilutions but
all samples gave reduced values between 0.1–0.2 at 1:400
dilution. The OD value of two samples from SFTS-con-
firmed patients was reduced from 2.2 at 1:400 dilution to
0.8 at 1:800 dilution. Thus, the dilution for IgM ELISA was
set at 1:400.
At the set serum dilutions, 1: 1000 for IgG and 1:400
for IgM, all the 94 healthy volunteer serum samples gave
an OD values between 0.1 and 0.2, hence, the cut-off for
giving a negative result was set at 0.4.
Evaluation of rSFTSV-N protein based indirect IgG ELISA
Among the 115 serum samples from SFTS-suspected
patients, 85 samples were positive by rSFTSV-N protein-
based indirect IgG ELISA and 30 were negative. The OD
value for negative samples ranged from 0.1 to 0.2, and from
0.4–2.6 for positive samples. These results perfectly
matched the results obtained by using the total antibody
Fig. 1 Expression and purification of recombinant SFTSV-N protein. a Schematic figure of the recombinant expression plasmid with the SFTSV-N
insert. b SDS-PAGE analysis of recombinant SFTSV-N protein. The proteins from the supernatant and pellet of the recombinant expressing E. coli cell lysate
and the purified recombinant protein were analyzed in a 5–20 % gradient SDS-PAGE gel which was stained with Coomassie brilliant blue. Lane 1: protein
marker (Precision plus protein standards, Bio-Rad); Lane 2: supernatant of sonicated E. coli cell lysate after centrifugation; Lane 3: pellet of sonicated E.coli
cell lysate; Lane 4: purified recombinant protein
Fig. 2 Western-blot analysis of purified SFTSV-N protein. a Reactivity of
recombinant protein to mouse anti-Histidine antibody. Lane 1: protein
marker (Precision plus protein standards); lane 2: purified SFTSV-N protein.
b Reactivity to SFTS patient serum. Lane 1: protein marker; lane 2: SFTSV
infected Vero-E6 cell lysates; lane 3: purified SFTSV-N protein
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ELISA kit. The sensitivity and specificity of rSFTSV-N-IgG
ELISA in comparison with the kit were 100 % (Table 1).
Evaluation of rSFTSV-N protein based indirect IgM ELISA
Among the 115 serum samples from SFTS-suspected
patients, 77 samples were positive and 38 were negative
by rSFTSV-N protein-based indirect IgM ELISA. The
OD values for negative samples ranged from 0.1 to 0.2,
and from 0.4–2.2 for positive samples. Our indirect IgM
ELISA failed to detect the eight samples that were positive
by the total antibody sandwich ELISA kit. Compared with
the kit, the sensitivity and specificity of the rSFTSV-N-
IgM capture ELISA were 90.59 and 100 %, respectively
(Table 2).
Discussion
In the present study, we expressed rSFTSV nucleocapsid
protein in E. coli and purified the recombinant protein
to near homogeneity by the his-tag based affinity chro-
matography under native conditions and used it as an
assay antigen in the indirect IgG and IgM ELISA.
Nucleocapsid protein is the most abundant protein in
many viruses and recombinant nucleocapsid protein has
been used for the sero-diagnosis of many viruses like,
SARS and Nipah viruses [28, 29]. In the Phlebovirus fam-
ily, RVF virus N protein is a good target for IgG and IgM
ELISA systems [24–26]. For SFTS virus, there has been
only one report on the development of an ELISA system
(double-antigen sandwich assay system) which makes use
of a recombinant N protein for detecting total antibodies
and this system was validated by neutralization test [27].
The total antibody ELISA kit used in the present study
was based on this system. In contrast to the preparation of
the recombinant N protein used in this antigen sandwich
assay system, our recombinant protein was mostly soluble
and was purified under native condition without using any
detergent thereby skipping the arduous work of refolding
the denatured protein. The expression and purification
procedures described in this study provide a simple and
efficient way to obtain pure SFTSV N protein in large
quantity.
Using this rSFTSV-N protein, we developed indirect
IgG and IgM ELISA for human serum, and compared with
a commercial total antibody detection sandwitch ELISA
kit. Evaluation of 115 serum samples from SFTSV-
suspected patients showed a concordance rate of 100
and 93.04 % for the IgG and IgM ELISA in comparison
with the total antibody detection sandwitch ELISA kit,
respectively. The sensitivity and specificity of the rSFTSV-
N protein based indirect IgG ELISA system were both
100 % with regard to total antibody detection sandwitch
ELISA kit (Table 1). The sensitivity and specificity of the
rSFTSV-N protein based indirect IgM ELISA system were
90.59 % and 100 % respectively, with regard to total anti-
body detection sandwitch ELISA kit (Table 2). The indir-
ect IgM ELISA system failed to catch eight samples that
were positive by the total antibody kit. This may be
caused by the lower sensitivity of indirect IgM ELISA
method or the IgM antibody against SFTSV did not
exist in these samples. All the 115 serum samples were
collected from SFTS suspected patients who recovered
after their illness and all the positive samples have the
specific IgG (Table 1). It is well known that the IgG
competes with the IgM in binding to antigen thereby
reducing the sensitivity of indirect IgM ELISA [30]. Still
our indirect IgM ELISA has a sensitivity of 90.59 %; it
is an acceptable level for clinical diagnosis, especially for
use in developing countries. For more sensitive diagnosis
method, we are currently developing an IgM capture
ELISA system.
The total antibody sandwich-ELISA system which was
developed by Jiao et al. was widely used in China because
it is simple to perform, could be used to human and all
kinds of animals. But the disadvantages of this method are
that it cannot distinguish IgG from IgM and that more
volume of the serum (serum used without dilution) is
required for the assay thus, limiting its application for
clinical diagnosis and large scale epidemiological studies.
Our SFTSV-N protein based systems detect IgG and IgM
separately, so it can distinguish previous or recent infection,
respectively. The serum dilution is 1:1000 for IgG and
1:400 for IgM; this greatly save the serum used and will be
Table 1 Sensitivity and specificity of SFTSV-N-IgG ELISA with
reference to the total antibody sandwitch ELISA kit
Sandwich ELISA SFTSV-N-IgG ELISA Total
Positive Negative
Positive 85 0 85
Negative 0 30 30
Total 85 30 115
Concordancea : 100 % Sensitivityb : 100 % Specificityc: 100 %
a(No. of samples positive by both methods + No. of samples negative by both
methods)/total number of samples × 100
bTrue positive/(true positive + false negative) × 100
CTrue negative/(true negative + false positive) × 100
Table 2 Sensitivity, and specificity of SFTSV-N-IgM ELISA with
reference to the total antibody sandwitch ELISA kit
Sandwich ELISA SFTSV-N-IgM ELISA Total
Positive Negative
Positive 77 8 85
Negative 0 30 30
total 77 38 115
Concordancea :93.04 % Sensitivityb :90.59 % Specificityc:100 %
a(No. of samples positive by both methods + No. of samples negative by both
methods)/total number of samples × 100
bTrue positive/(true positive + false negative) × 100
CTrue negative/(true negative + false positive) × 100
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quite beneficial for precious samples and large scale epi-
demiological studies.
The rSFTSV-N protein based indirect IgG and IgM
ELISA systems presented here eliminate the use of infec-
tious virus in the antigen production, which requires
high level of microbiological security facilities. Hence
they are safer methods for diagnosis. The expression and
purification procedure for recombinant SFTSV-N pro-
tein is simple and easy allowing an easy standardization
of the antigen production. The advantages of using a
prokaryotic host to produce recombinant SFTSV-N pro-
tein would be considerable due to the ease of scale-up,
and the low costs involved in growing bacteria. It would
be especially useful in cases of large-scale epidemio-
logical investigation and for application in developing
countries.
Conclusion
In conclusion, the rSFTSV-N protein is highly immuno-
reactive in human infection and it is a good target for la-
boratory diagnosis. Our rSFTSV-N protein-based IgG
and IgM ELISA systems are safe, specific and sensitive
tools for serological diagnosis of SFTS virus infections




Two serum samples from SFTS-confirmed patients col-
lected in 2014 and 94 serum samples from healthy volun-
teers collected in 2004–several years before the earliest
identified SFTS patient was reported–were used as posi-
tive and negative controls, respectively, in determining the
serum dilution for the IgG and IgM indirect ELISA we de-
veloped in the present study. To evaluate these two assays,
115 serum samples collected in 2013 in Henan Province,
China were used in this study. These samples were col-
lected from patients who recovered from an illness that
was suspected to be SFTS.
Virus inoculation and RNA extraction
The Yamaguchi strain of SFTSV (GenBank accession no.
AB817995, AB817987, and AB817979) that was isolated
in 2013 from a patient in Yamaguchi Prefecture, Japan
was inoculated to confluent monolayer of Vero-E6 cells.
These cells were then maintained at 37 °C in Eagle’s Mini-
mum Essential Medium supplemented with 2 % fetal calf
serum and 0.2 mM of each non-essential amino acids for
5 days. The infected culture fluid (ICF) was harvested and
from a 140 μl of this ICF, viral RNA was extracted using
the QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
The extracted RNA was eluted in 60 μl of elution buffer
and then used as template for RT-PCR.
Construction of recombinant plasmid
RT-PCR was performed by using the primers 5’- GGAG
CATGCATGTCGGAGTGGTCCAGG-3’ and 5’-AATAA
GCTTTTACAGGTTTCTGTAAGCA-3’ to generate the
full length N gene of SFTSV. Sense and reverse primers
contained SphI and Hind III restriction sites (underlined),
respectively. The PCR amplified DNA fragments were
digested with SphI and Hind III, purified by a QIAEX II
gel extraction kit (Qiagen, Hilden, Germany), and subse-
quently cloned into the corresponding restriction site of
the pQE30 vector (Qiagen, Hilden, Germany). The insert
of recombinant plasmid was confirmed to be in frame by
DNA sequencing. The expression construct encompassing
amino acid (aa) 1–246, the full length of SFTSV N protein
with a vector derived His-tag (histidine hexmer) at the
N-terminus, was obtained. The resultant recombinant
protein was designated as rSFTSV-N protein.
Expression and purification of the recombinant SFTSV- N
protein
The rSFTSV-N protein was expressed by inserting the
recombinant plasmid containing the SFTSV-N sequence
into E. coli strain XL-1 blue and cultured at 37 °C in
Luria-Bertani (LB) medium containing 100 μg/ml of ampi-
cillin. When the optical density (OD 600 nm) of the
culture reached 1.0, the expression of recombinant pro-
tein was induced for 3 h by the addition of 0.2 mM iso-
propyl β-D-thiogalactoside (IPTG). After harvest by
centrifugation, the E. coli pellet was washed in phosphate
buffered saline solution (PBS), then resuspended in 10 mM
PBS pH 7.5 with 500 mM NaCl and frozen at −80 °C. After
freezing and thawing three times, the cell suspension was
sonicated for 2 min with an interval of 1 s between pulses
and centrifuged at 30,000 g for 15 min at 4 °C. The super-
natant was then applied to a Talon™ IMAC resin column
(Clontech, USA). After being washed with a binding buffer
(10 mM PBS with 500 mM NaCl containing 20 mM imid-
azole, pH 7.5), the purified protein was eluted with an elu-
tion buffer (10 mM PBS with 500 mM NaCl containing
250 mM imidazole, pH 7.5). The protein solution was
aliquoted and stored in a final concentration of 10 %
glycerol at −80 °C until use. Protein concentrations were
determined by the Bradford method using a Bio-Rad
protein assay reagent kit (Bio-Rad, USA), and the purity
of the protein was analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE).
Western blot analysis
Western blot analysis was performed as described before
[28]. Briefly, protein marker (Precision plus protein stan-
dards, Bio-Rad), SFTSV infected Vero-E6 cell lysates and
the purified recombinant protein were separated in a
5–20 % gradient polyacrylamide gel (ATTO Corporation,
Japan) before being electrotransferred onto a PVDF
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membrane (Immobilon, Millipore, USA) by using a
semidry electroblotter (Sartorius, Germany). The membrane
was blocked with Blockace (Yokijirushi, Sapporo, Japan)
overnight at 4 °C to prevent nonspecific staining, then
subjected to reaction with mouse anti-histidine (GE
Healthcare Life Sciences,1:1000 dilution), or patient
serum sample (1:100 dilution) for 1 h at 37 °C before
incubation with rabbit anti-mouse IgG, or goat anti-
human peroxidase conjugate (American Qualex, Califonia,
USA,1:1000 dilution) for 1 h at 37 °C. Finally, the reaction
was visualized by dimethyl aminobenzidine (DAB) staining.
Determination of serum dilution for indirect IgG and IgM
Serum samples from two SFTS-confirmed patients and
from 94 healthy volunteers were diluted at 1:100, 1:200,
1:400, 1:800 and 1:1000 dilutions. The diluted sera were
checked by rSFTSV-N based indirect IgG and IgM ELISA
separately as described below. The appropriate dilution of
the serum samples for these two assays was determined
based on OD values at 410 nm.
ELISA procedures using the recombinant nucleocapsid
protein
To evaluate the usefulness for diagnosis of the rSFTSV-N
protein we developed, we established an indirect IgG and
IgM ELISA for the laboratory diagnosis of SFTSV infec-
tion in humans with the serum samples as clinical speci-
mens. These assays have common procedures which will
be described here and the procedures specific for each
assay will be described under each assay. The plates used
were 96-well Nunc immunoplates (Thermo Scientific,
Denmark), and all the reagents were in 100 μL volumes.
The optimal concentration of rSFTSV-N protein used
to coat the microplates was determined by checkerboard
titration with reference serum samples (2 from SFTS-
confirmed patients and 2 from healthy volunteers). The
coating buffer was 0.01 M PBS, pH 7.4, and plate coating
was conducted at 4 °C overnight. Wash buffer was 0.01 M
PBS with 0.1 % (vol/vol) Tween 20 (PBS-T). Plates were
washed three times with PBS-T after exposure to a specific
reagent at each step of the procedure except at the last
step as described below. Dilution of all serum samples and
reagents were in 5 % nonfat milk (Difco, Detroit, USA) in
PBS-T. Incubations, except for substrate, were done for
1 h at 37 °C. Plates with 100 μL H2O2-ABTS substrate (Kir-
kegaatrd & Perry, Gaithersburg, MD) in each well were in-
cubated for 30 min at 37 °C. The plates were read
spectrophotometrically and OD values at 410 nm were
recorded.
Indirect IgG ELISA
In the indirect IgG ELISA, 96-well plates were subjected
to the following steps: coating of each well with 50 ng
rSFTSV-N protein per well followed by human serum
samples that were diluted 1:1,000 in 5 % nonfat milk in
PBS-T, then detection of bound IgG with 1:30,000 diluted
horseradish-peroxidase-conjugated goat anti-human IgG
(American Qualex, Califonia, USA) which was made vis-
ible after adding H2O2-ABTS substrate, the last reagent in
this series of procedure. OD values at 410 nm were re-
corded on a microplate spectrophotometer. Each serum
sample was tested in duplicate, and the mean OD for each
sample was calculated. Reference serum samples were run
in every assay. The mean OD of a sample more than twice
the mean OD of the negative control serum was consid-
ered positive.
Indirect IgM ELISA
The procedure for indirect IgM ELISA was similar to
IgG ELISA. The changes were that the serum samples
were diluted at 1:400 and the detection of bound IgM
was donewith 1:10,000 diluted horseradish peroxidase-
conjugated goat anti-human IgM (American Qualex,
Califonia, USA).
Detection of total SFTSV antibody
Serum samples from suspected SFTS patients were sub-
jected to a commercial ELISA kit (Xinlianxin Biomedical
Technology CO., LTD, Wuxi, Jiangsu, China) following
the manufacturer’s protocol. The kit is a double-antigen
sandwich enzyme-linked immunosorbent assay kit that
detects total antibodies including IgG and IgM against
SFTSV [27]. Results obtained by using this total antibody
ELISA kit was compared to the results obtained by apply-
ing the IgG and IgM indirect ELISA described above.
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